Target intelligence / Profile preview

Salmonella Paratyphi A lipopolysaccharide O:2 antigen (O:2 antigen)

Target
O:2 antigen
Molecular classification
Bacterial surface antigen, Lipopolysaccharide, O-polysaccharide
01

Overview

Salmonella Paratyphi A lipopolysaccharide O:2 antigen is a key surface-exposed polysaccharide found on the outer membrane of Salmonella enterica serovar Paratyphi A [Bio-Rad, FEMS Microbiology Reviews]. This bacterium is a major cause of paratyphoid fever, a systemic febrile illness similar to typhoid fever that is prevalent in South and Southeast Asia [Vaccines for AMR, NIH]. The O:2 antigen is a part of the lipopolysaccharide (LPS) molecule and is distinguished by the presence of paratose, a 3,6-dideoxyhexose sugar that defines the O2 serogroup [Coalition Against Typhoid, FEMS Microbiology Reviews]. It plays a vital role in bacterial pathogenesis by contributing to serum resistance and protecting the organism from the host's innate immune system [Bio-Rad, NIH]. As a highly immunogenic component, it is the primary target for the development of paratyphoid conjugate vaccines [Vaccines for AMR, NIH]. These vaccines aim to induce high titers of anti-O:2 IgG antibodies, which provide protection through complement-mediated bactericidal activity and opsonophagocytosis [NIH]. Currently, several bivalent vaccines combining this antigen with the S. Typhi Vi antigen are in clinical development to provide broad protection against enteric fever [NIH].

Other names
Salmonella Paratyphi A O-antigenO2 antigenParatyphi A O-specific polysaccharideO-SPSalmonella enterica serovar Paratyphi A LPSGroup A O-antigen
02

Mechanism of action

Induction of protective serum IgG antibodies that provide bactericidal activity and facilitate opsonophagocytosis of Salmonella Paratyphi A [NIH, Vaccines for AMR].

03

Biological functions

Bacterial virulenceImmune evasionStructural integrityHost-pathogen interaction
04

Disease associations

InfectionParatyphoid feverEnteric fever
05

Safety considerations

Serotype specificity (no cross-protection against S. Typhi) [Vaccines for AMR]Potential for endotoxicity if not properly purified [Bio-Rad]Hypersensitivity to carrier proteins [NIH]
06

Interacting drugs

O:2-CRM197 conjugate vaccine

2 more in the full profile.

07

Biomarkers

Anti-O:2 IgG antibody titer [NIH]Serum bactericidal activity (SBA) [NIH]

Beyond the preview

Go deeper on Salmonella Paratyphi A lipopolysaccharide O:2 antigen (O:2 antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Paratyphi A lipopolysaccharide O:2 antigen (O:2 antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call